PHILADELPHIA, PA / ACCESSWIRE / October 8, 2019 / Kaskela Law LLC is investigating Livongo Health, Inc. ("Livongo" or the "Company") (NASDAQ:LVGO) on behalf of investors.
The investigation seeks to determine whether Livongo and/or the Company's officers and directors violated the securities laws in connection with Livongo's July 2019 initial public offering ("IPO") of securities, and whether investors have been harmed as a result of such actions.
On or about July 24, 2019, Livongo completed its IPO of common stock by selling 12.7 million shares of stock to investors at $28.00 per share.
Less than six weeks after the IPO, on September 5, 2019, Livongo reported its first quarterly financial and operational results (for the quarter ended June 30, 2019) as a public company, which included a net loss of $14.2 million (approximately ($0.76 per share)) for the quarter. Following this news, shares of the Company's stock declined $5.34 per share, or over 17% in value.
Livongo investors who purchased shares of the Company's stock between July 24, 2019 and September 5, 2019 are encouraged to contact Kaskela Law LLC at (888) 715-1740, or online at http://kaskelalaw.com/case/livongo-health-inc/, to discuss this investigation and their legal rights and options.
Kaskela Law LLC exclusively represents investors in securities fraud and shareholder rights litigation in state and federal actions. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com. This notice may constitute attorney advertising in certain jurisdictions.
CONTACT:
D. Seamus Kaskela, Esq.
KASKELA LAW LLC
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 258 - 1585
(888) 715 - 1740
www.kaskelalaw.com
[email protected]
SOURCE: Kaskela Law LLC